KR880002223B1 - 정제해독된 내독소 - Google Patents
정제해독된 내독소 Download PDFInfo
- Publication number
- KR880002223B1 KR880002223B1 KR1019840005189A KR840005189A KR880002223B1 KR 880002223 B1 KR880002223 B1 KR 880002223B1 KR 1019840005189 A KR1019840005189 A KR 1019840005189A KR 840005189 A KR840005189 A KR 840005189A KR 880002223 B1 KR880002223 B1 KR 880002223B1
- Authority
- KR
- South Korea
- Prior art keywords
- endotoxin
- rde
- detoxified
- composition
- purified
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52696783A | 1983-08-26 | 1983-08-26 | |
US526967 | 1983-08-26 | ||
US526,967 | 1983-08-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR850001696A KR850001696A (ko) | 1985-04-01 |
KR880002223B1 true KR880002223B1 (ko) | 1988-10-20 |
Family
ID=24099553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019840005189A KR880002223B1 (ko) | 1983-08-26 | 1984-08-25 | 정제해독된 내독소 |
Country Status (22)
Country | Link |
---|---|
JP (1) | JPS6072825A (nl) |
KR (1) | KR880002223B1 (nl) |
AT (1) | AT389228B (nl) |
AU (1) | AU554039B2 (nl) |
BE (1) | BE900377A (nl) |
CA (1) | CA1225592A (nl) |
CH (1) | CH660125A5 (nl) |
DE (2) | DE3448164C2 (nl) |
DK (1) | DK389384A (nl) |
ES (1) | ES8606883A1 (nl) |
FI (1) | FI843204A (nl) |
FR (1) | FR2550945B1 (nl) |
GB (1) | GB2147806B (nl) |
HU (1) | HU191713B (nl) |
IL (1) | IL72675A (nl) |
IN (1) | IN157910B (nl) |
IT (1) | IT1177974B (nl) |
NL (1) | NL192326C (nl) |
NO (1) | NO843243L (nl) |
NZ (1) | NZ209233A (nl) |
SE (1) | SE8404090L (nl) |
ZA (1) | ZA846309B (nl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4629722A (en) * | 1984-07-12 | 1986-12-16 | Ribi Immunochem Research, Inc. | Method of inhibiting the onset of acute radiation syndrome |
US4803070A (en) * | 1986-04-15 | 1989-02-07 | Ribi Immunochem Research Inc. | Immunological emulsion adjuvants for polysaccharide vaccines |
US4806352A (en) * | 1986-04-15 | 1989-02-21 | Ribi Immunochem Research Inc. | Immunological lipid emulsion adjuvant |
DE10115310A1 (de) * | 2001-03-28 | 2002-10-10 | Nodar A Daniela | Bakteriophagen-Präparation |
KR100868443B1 (ko) * | 2002-05-27 | 2008-11-11 | 주식회사 포스코 | 폭과 길이가 가변 조정되는 런치박스 제작장치 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2160326B1 (nl) * | 1971-11-19 | 1975-02-07 | Anvar | |
BE793260A (fr) * | 1971-12-24 | 1973-06-22 | Pasteur Institut | Agent immunostimulant, medicaments le contenant et procede de fabrication de cet agent immunostimulant |
DE2527636A1 (de) * | 1974-06-20 | 1976-01-08 | Anvar | Verfahren zur herstellung von mycobakteriellen fraktionen |
FR2393065A1 (fr) * | 1977-05-31 | 1978-12-29 | Merieux Inst | Procede de separation de lipides d'endotoxines bacteriennes et notamment d'endotoxine de bordetella pertussis |
US4436727A (en) * | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
US4436728A (en) * | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
US4435386A (en) * | 1982-05-26 | 1984-03-06 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
-
1984
- 1984-08-10 CA CA000460820A patent/CA1225592A/en not_active Expired
- 1984-08-13 DK DK389384A patent/DK389384A/da not_active Application Discontinuation
- 1984-08-14 ZA ZA846309A patent/ZA846309B/xx unknown
- 1984-08-14 GB GB08420612A patent/GB2147806B/en not_active Expired
- 1984-08-14 IN IN567/CAL/84A patent/IN157910B/en unknown
- 1984-08-14 FI FI843204A patent/FI843204A/fi not_active Application Discontinuation
- 1984-08-14 SE SE8404090A patent/SE8404090L/xx not_active Application Discontinuation
- 1984-08-14 IL IL72675A patent/IL72675A/xx not_active IP Right Cessation
- 1984-08-14 NO NO843243A patent/NO843243L/no unknown
- 1984-08-14 ES ES535124A patent/ES8606883A1/es not_active Expired
- 1984-08-15 NZ NZ209233A patent/NZ209233A/en unknown
- 1984-08-16 NL NL8402515A patent/NL192326C/nl not_active IP Right Cessation
- 1984-08-17 BE BE0/213506A patent/BE900377A/fr not_active IP Right Cessation
- 1984-08-21 CH CH4001/84A patent/CH660125A5/de not_active IP Right Cessation
- 1984-08-21 AU AU32215/84A patent/AU554039B2/en not_active Expired
- 1984-08-23 DE DE3448164A patent/DE3448164C2/de not_active Expired
- 1984-08-23 HU HU843169A patent/HU191713B/hu unknown
- 1984-08-23 DE DE19843431058 patent/DE3431058A1/de active Granted
- 1984-08-23 FR FR8413133A patent/FR2550945B1/fr not_active Expired
- 1984-08-24 IT IT48757/84A patent/IT1177974B/it active
- 1984-08-25 KR KR1019840005189A patent/KR880002223B1/ko not_active IP Right Cessation
- 1984-08-25 JP JP59175877A patent/JPS6072825A/ja active Granted
- 1984-08-27 AT AT0273384A patent/AT389228B/de not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4866034A (en) | Refined detoxified endotoxin | |
KR870000842B1 (ko) | 정제 해독된 내독소 및 그의 제조방법 | |
US4436728A (en) | Refined detoxified endotoxin product | |
US4435386A (en) | Refined detoxified endotoxin product | |
US4877611A (en) | Vaccine containing tumor antigens and adjuvants | |
CA1181691A (en) | Vaccinal complex containing a specific antigen and vaccine containing it | |
Nowotny et al. | Relation of Structure to Function in Bacterial Endotoxins: VIII. Biological Activities in a Polysaccharide-Rich Fraction | |
US4505900A (en) | Refined detoxified endotoxin product | |
KR870000843B1 (ko) | 피리딘 가용성 추출물의 제조방법 | |
Adam et al. | Preparation and biological properties of water-soluble adjuvant fractions from delipidated cells of Mycobacterium smegmatis and Nocardia opaca | |
EP0375808A1 (en) | Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and a kit of parts | |
US4505899A (en) | Refined detoxified endotoxin product | |
Fukushi et al. | Extraction and purification of endotoxin from Enterobacteriaceae: a comparison of selected methods and sources | |
US4152423A (en) | Immunological agents | |
KR880002223B1 (ko) | 정제해독된 내독소 | |
JP2709979B2 (ja) | マイコバクテリウムケロナエの極性糖ペプチド脂質に基づく免疫刺激薬 | |
Berger et al. | Increased host resistance to infection elicited by lipopolysaccharides from Brucella abortus | |
HU185315B (en) | Siliconpolymer compositions for treating textile materials | |
IL165970A (en) | Method of isolating biologically active fraction containing clinically acceptable native s-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides | |
Behling et al. | Immunostimulation by LPS and its derivatives | |
RU2111012C1 (ru) | Вакцинный препарат для профилактики брюшного тифа | |
AU615016B2 (en) | Immunological adjuvent and process for preparing the same, pharmaceutical compositions, and process | |
KITAGAWA et al. | Chemical Studies on Cellular Components of Hemophilus pertussis II. Isolation of Toxic Lipopolysaccharide | |
Lederer | Cord factor and related synthetic trehalose diesters | |
Tian | Isolation, characterization and formulation of antineoplastic proteoglycans from mycobacterium vaccae |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application | ||
J2X1 | Appeal (before the patent court) |
Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL |
|
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
LAPS | Lapse due to unpaid annual fee |